conclusions this study showed a low rate of isolated anti-hbc and occult hbv infection in hd patients. it can be due to improvement of people’s knowledge about hbv transmission routes, hbv vaccination of hd patients and regular surveillance of hbv infection. results a hundredpatients with a mean age of 58.5 ± 16.1 years were enrolled in this study. in total, 56.7% were male and 43.3% female. an...

The relationship between acute myeloid leukemia (AML), acute lymphocytic leukemia, chronic myeloid leukemia (CML), and refractory anemia with excess of blasts (RAEB) and antibodies to human T-cell lymphotropic virus types I and II (HTLV-I and HTLV-II), and hepatitis B virus and hepatitis C virus (HCV) was investigated in a multicenter case-control study. There were 431 cases enrolled in the stu...

Hepaxpert-I is an expert system that interprets the results of routine serologic tests for infection with hepatitis A or B virus. The tests measure antibody to the hepatitis A virus (anti-HAV), IgM antibody to the hepatitis A virus (IgM anti-HAV), hepatitis A virus (HAV) in the stool, hepatitis B surface antigen (HBsAg) and antibody (anti-HBs), antibody to hepatitis B core antigen (anti-HBc and...

introduction: vaccination with the major surface antigen of hepatitis b virus (hbsag) induces anti-hbs antibody production and level of 10 iu/l is considered protective. it has been shown that the level of anti-hbs antibody does wane after vaccination. the aim of this study was to evaluate the persistence of anti-hbs antibodies in healthy iranian children 10 years after primary vaccination. met...

In this cross sectional anonymous study, blood samples of 285 dentists and Physicians were tested for hepatitis B surface antigen (HBs Ag), hepatitis B envelope Ag (HBe Ag), antibodies to: hepatitis B suface (anti-HBs), hepatitis B core Ag (anti-HBc) and hepatitis B envelope Ag (anti-HBe) by ELISA-3 and antibody to hepatitis C virus (anti-HCV) by ELISA-3 and immunoblotting tests. The results su...

Background & Aims: Hepatitis B virus is one of the causes of acute and chronic hepatitis. Due to multiple hospitalization and blood transfusion, thalassaemic patients are at higher risk of this infection. Duration of the immunity after vaccination in this high-risk group and the need for booster vaccination is uncertain. The aim of this study was to find antibody titration and immunity to Hepat...

background hepatitis b virus (hbv) infection is a major public health problem that affects billions of people worldwide. the lack of information on hbv prevalence among the general population is an obstacle to formulate effective policies to reduce the burden of viral hepatitis. objectives this population based serological survey was conducted in kermanshah province to determine the local preva...

In order to determine the efficacy of recombinant hepatitis B vaccine in Iranian infants, we analyzed the efficacy of a recombinant hepatitis B vaccine in 115 infants aged 12-24 months born to HBsAg negative mothers who received three doses of HBV Antibody to hepatitis B surface antigen (anti-HBs) was checked after the third dose of the vaccine, 94.8% of the infants had developed protective...

A sensitive enzyme immunoassay (EIA) specific for hepatitis B virus core antigen (HBcAg) and hepatitis B e antigen (HBeAg) was developed. We designated the precore/core gene products as hepatitis B virus (HBV) core-related antigens (HBcrAg). In order to detect HBcrAg even in anti-HBc/e antibody-positive specimens, the specimens were pretreated in detergents. The antibodies are inactivated by th...